Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report
Actinogen locked the XanaMIA database late on 20 October 2026 and announced the milestone the next day, narrowing earlier guidance of November to mid-November for topline results. The final participant visit took place in the United States on 22 September, and the trial is …
The agreement covers cross-border e-commerce only, including platforms such as Tmall Global, Douyin, PDD and RedNote. The term runs from signing, and no earlier than 1 November 2026, to 31 December 2029. Year 1 is unconditional exclusivity, which runs to 31 December 2027.
The patent is titled Formulations and Methods for Treating Erectile Dysfunction and protects defined formulation characteristics relating to the company’s intranasal technology. The release does not reproduce the claims, so the precise scope of protection is not described in detail beyond the company’s general …
The poorly controlled diabetes rate fell from 13.1% at about six months to 6.7% at about 12 months, against a national benchmark of 28.1%. Blood pressure control rose from 79.6% to 82.9%, and depression screening and follow-up improved from 70.3% to 79.5%. The company …
Ramsay Health Care released Ramsay Santé’s results for the three months ended 30 September 2026 on 6 November. Ramsay held 52.79% of the subsidiary. The EuropeanBusinessreported revenue of EUR1,232.9 million, increasing 2.9% year on year, or 2.6% at constant exchange rates. These areSubsidiaryfigures and …
The US Centers forMedicare& Medicaid Services assigned the Minder implant procedure to Ambulatory Payment Classification 5117 under the 2027 Hospital Outpatient Prospective Payment System rule.
BTC Cardio signed a revised exclusive agreement with UK manufacturer Exstent, covering India alongside Australia.
Mayne Pharma agreed to sell all shares in Mayne Pharma International Pty Ltd for AUD 55.5 million in cash at completion, subject to customary working-capital adjustments.
The final Local Coverage Determination for urine-based biomarkers in patients with microhematuria, identified as L40378, confirms coverage for Cxbladder Triage and Triage Plus.
TotalRevenuefor the three months ended 30 September 2026 was US$26.114 million, up from US$17.062 million a year earlier.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…